VA ECMO vs VV ECMO: Indications, Differences, Cost Comparison, Cannulation

Content:

• What is VA ECMO vs VV ECMO?
• VA ECMO vs VV ECMO Indications
• VA ECMO vs VV ECMO Differences
• VA ECMO vs VV ECMO Cost Comparison
• VA ECMO vs VV ECMO Cannulation

What is VA ECMO vs VV ECMO?

VA ECMO and VV ECMO are two major forms of extracorporeal membrane oxygenation used to provide temporary life support when a patient’s heart, lungs, or both cannot maintain adequate circulation and oxygen delivery. ECMO removes blood from the body through a drainage cannula, passes it through an artificial lung that adds oxygen and removes carbon dioxide, and returns the treated blood through another cannula. The key difference lies in where the blood is returned. In venoarterial ECMO, blood is returned to an artery, so the system supports both circulation and gas exchange. In venovenous ECMO, blood is returned to a vein, so it supports the lungs but depends on the patient’s heart to continue pumping blood through the body.

Both techniques are generally considered rescue therapies rather than treatments for the underlying disease. They provide time for the heart or lungs to recover, for doctors to establish a diagnosis, or for the patient to receive another treatment such as transplantation or a long-term ventricular assist device. VV ECMO is commonly described in adult respiratory-failure guidance as support for severe, potentially reversible respiratory failure that remains life-threatening despite optimal conventional treatment. VA ECMO is used when inadequate cardiac output produces shock, poor tissue perfusion, or cardiac arrest. Selection must be made by an experienced multidisciplinary ECMO team because the therapy requires large vascular cannulas, anticoagulation, continuous monitoring, and management of potentially serious complications.

VA ECMO vs VV ECMO Indications

VA ECMO indications primarily involve severe cardiac failure with inadequate circulation. Examples include refractory cardiogenic shock following a large myocardial infarction, fulminant myocarditis, severe decompensated cardiomyopathy, failure to separate from cardiopulmonary bypass, acute right-ventricular failure, massive pulmonary embolism with cardiovascular collapse, and selected cases of cardiac arrest treated with extracorporeal cardiopulmonary resuscitation. The patient typically has persistent hypotension, reduced cardiac output, rising lactate, or signs of organ hypoperfusion despite appropriate fluids, medications, ventilation, and other conventional therapies. VA ECMO may serve as a bridge to myocardial recovery, heart transplantation, a durable ventricular assist device, or a decision about long-term treatment. It is not appropriate when recovery or another meaningful destination is impossible.

VV ECMO indications focus on severe respiratory failure when cardiac pumping function remains adequate. Common examples include severe acute respiratory distress syndrome, viral or bacterial pneumonia, aspiration, pulmonary contusion, inhalational injury, diffuse alveolar hemorrhage, and selected cases awaiting lung transplantation. It may be considered when severe hypoxemia or uncontrolled hypercapnia continues despite lung-protective mechanical ventilation, adequate positive end-expiratory pressure, prone positioning, and other evidence-based measures. VV ECMO does not directly raise arterial blood pressure or replace cardiac output. Therefore, a patient with combined respiratory failure and profound circulatory shock may need VA ECMO or another hybrid configuration instead. ELSO’s adult respiratory guidance addresses patient selection, initiation, cannulation, management, and weaning for VV ECMO.

VA ECMO vs VV ECMO Differences

The most important difference is the type of organ support provided. VA ECMO supports the heart and lungs because oxygenated blood is pumped directly into the arterial circulation. It can increase systemic blood flow and maintain organ perfusion when the heart is unable to do so. VV ECMO supports gas exchange only. Oxygenated blood returns to the venous system, travels through the right side of the heart, and is then pumped into the systemic circulation by the patient’s own heart. Consequently, VV ECMO requires adequate cardiac function, whereas VA ECMO can maintain circulation during severe ventricular failure or cardiac arrest.

Their risk profiles also differ. Both can cause bleeding, infection, hemolysis, thrombosis, low platelet counts, and cannula-related complications. VA ECMO has additional arterial risks, including limb ischemia, arterial injury, embolic stroke, differential hypoxemia, and increased left-ventricular afterload. Distal limb-perfusion cannulas and left-heart unloading strategies may be required in selected patients. VV ECMO generally avoids direct arterial cannulation, so limb ischemia and arterial embolization are less prominent concerns. However, recirculation may occur when oxygenated blood is drawn back into the drainage cannula rather than reaching the patient. Careful cannula positioning, flow adjustment, echocardiography, blood-gas monitoring, and evaluation of oxygen delivery are essential in both configurations.

Feature	VA ECMO	VV ECMO
Main support	Heart and lungs	Lungs only
Blood return	Artery	Vein
Typical indication	Cardiogenic shock or cardiac arrest	Severe respiratory failure or ARDS
Needs functioning heart	Not necessarily	Yes, adequate circulation is required
Major configuration-specific risk	Arterial injury, stroke and limb ischemia	Recirculation and inadequate oxygen delivery

VA ECMO vs VV ECMO Cost Comparison

Both VA and VV ECMO are extremely resource-intensive therapies. The total cost includes the ECMO circuit, oxygenator, cannulas, emergency or operating-room placement, perfusion services, continuous ICU nursing, mechanical ventilation, laboratory monitoring, imaging, anticoagulation, medications, blood products, and treatment of complications. The largest financial factor is often not the circuit itself but the length and complexity of the intensive-care stay. A patient receiving ECMO for a few days without major complications may generate a substantially lower bill than someone supported for several weeks with kidney failure, infection, bleeding, surgery, or rehabilitation needs.

There is no dependable universal price showing that VA ECMO always costs more or less than VV ECMO. VA cases may involve emergency cannulation, cardiac catheterization, surgery, ventricular unloading, and arterial complications. VV cases may continue longer because recovery from severe lung injury can take weeks, producing high ICU, staffing, and equipment costs. A 2025 US hospital-cost analysis reported wide variation in both VA- and VV-ECMO costs and payments, demonstrating that configuration alone does not determine the final expense. Costs differ by country, hospital, duration, insurance arrangement, complications, and whether transplantation or another device is required. For patient-specific estimates, the treating hospital’s financial department is more reliable than a general online figure. 

VA ECMO vs VV ECMO Cannulation

VA ECMO cannulation requires venous drainage and arterial return. In peripheral VA ECMO, a large drainage cannula is commonly placed in a femoral vein and advanced toward the inferior vena cava or right atrium, while the return cannula is placed in a femoral artery. Because the arterial cannula may reduce blood flow to the leg, a smaller distal-perfusion cannula is often inserted to maintain circulation below the cannulation site. Other approaches include axillary or subclavian arterial return and central cannulation of the right atrium and ascending aorta during cardiac surgery. Peripheral cannulation is faster and suitable for emergencies, while central cannulation may permit higher flow but requires surgical access and carries substantial bleeding risk.

VV ECMO cannulation uses veins for both drainage and return. A common two-cannula configuration drains blood through a femoral venous cannula and returns oxygenated blood through an internal-jugular venous cannula. Femoral–femoral venous configurations may also be used. Another option is a dual-lumen cannula inserted through the right internal jugular vein, designed to drain blood from the venae cavae and direct oxygenated blood toward the tricuspid valve. Accurate positioning is important because poor alignment can increase recirculation and reduce effective oxygenation. Ultrasound, fluoroscopy, transesophageal echocardiography, or transthoracic echocardiography may guide placement. Cannulation strategy depends on patient size, anatomy, urgency, mobility goals, available expertise, and anticipated support duration. ELSO guidance includes practical recommendations on VV ECMO initiation and cannulation.

Medical note: ECMO is a highly specialized intensive-care therapy. Indications, cannulation configuration, anticoagulation, and weaning decisions must be individualized by an experienced ECMO team.